We are live on ! Find out more
MCP

Martin Capital Partners Portfolio holdings

AUM $272M
1-Year Est. Return 19.09%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$261M
AUM Growth
+$15.4M
Cap. Flow
+$3.88M
Cap. Flow %
1.49%
Top 10 Hldgs %
29.74%
Holding
72
New
2
Increased
16
Reduced
45
Closed
3

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$4.54M
2
O icon
Realty Income
O
+$4.28M
3
PFE icon
Pfizer
PFE
+$2.68M
4
SWKS icon
Skyworks Solutions
SWKS
+$1.08M
5
TROW icon
T. Rowe Price
TROW
+$780K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.33M
2
JPM icon
JPMorgan Chase
JPM
+$2.97M
3
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$2.37M
4
AMGN icon
Amgen
AMGN
+$252K
5
USB icon
US Bancorp
USB
+$210K

Sector Composition

Rank Sector Weight
1 Healthcare 15.69%
2 Consumer Staples 15.16%
3 Industrials 14.98%
4 Technology 10.52%
5 Energy 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INGR icon
51
Ingredion
INGR
$6.58B
$804K 0.31%
6,884
-576
-8% -$64.9K
CHRW icon
52
C.H. Robinson
CHRW
$17.5B
$736K 0.28%
9,661
+1,551
+19% +$121K
HII icon
53
Huntington Ingalls Industries
HII
$12.8B
$716K 0.27%
2,458
-30
-1% -$8.26K
WHR icon
54
Whirlpool
WHR
$2.82B
$690K 0.26%
5,766
+478
+9% +$53.3K
BKH icon
55
Black Hills Corp
BKH
$5.68B
$599K 0.23%
10,972
+3,362
+44% +$176K
CMA
56
DELISTED
Comerica
CMA
$587K 0.23%
10,667
+93
+0.9% +$4.85K
AAPL icon
57
Apple
AAPL
$4.57T
$582K 0.22%
3,395
– –
ALSN icon
58
Allison Transmission
ALSN
$9.82B
$548K 0.21%
6,751
-144
-2% -$9.71K
HRL icon
59
Hormel Foods
HRL
$13.8B
$543K 0.21%
15,549
+4,042
+35% +$129K
SNA icon
60
Snap-on
SNA
$21.5B
$534K 0.2%
1,804
-6
-0.3% -$1.7K
LLY icon
61
Eli Lilly
LLY
$1.06T
$389K 0.15%
500
– –
COST icon
62
Costco
COST
$420B
$355K 0.14%
485
– –
BWZ icon
63
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$270M
$351K 0.13%
13,323
-852
-6% -$22.7K
CNP icon
64
CenterPoint Energy
CNP
$26.8B
$280K 0.11%
9,825
+131
+1% +$3.67K
PAI
65
Western Asset Investment Grade Income Fund
PAI
$114M
$277K 0.11%
22,750
-3,300
-13% -$39.6K
FAX
66
abrdn Asia-Pacific Income Fund
FAX
$600M
$254K 0.1%
15,134
-1,359
-8% -$22K
SCHD icon
67
Schwab US Dividend Equity ETF
SCHD
$105B
$239K 0.09%
8,904
– –
AWF
68
AllianceBernstein Global High Income Fund
AWF
$872M
$119K 0.05%
11,179
– –
GILD icon
69
Gilead Sciences
GILD
$165B
– –
-41,064
Closed -$3.33M
SDY icon
70
State Street SPDR S&P Dividend ETF
SDY
$23.9B
– –
-18,961
Closed -$2.37M
USB icon
71
US Bancorp
USB
$99.6B
– –
-4,847
Closed -$210K
1 2
3

Similar funds

SC
Seldon Capital San Francisco, California $272M AUM 90.68% 1-Year Est. Return
SC
Swan Capital Pensacola, Florida $272M AUM 14.84% 1-Year Est. Return
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return

Martin Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Martin Capital Partners held 72 positions worth $261M, up 6.3% from $245M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Martin Capital Partners's Q1 2024 filing shows 2 new, 16 increased, 45 reduced and 3 closed positions. Its largest new stake was Hershey: 23,510 shares worth $4.57M. The largest sale was Gilead Sciences, an estimated $3.33M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Industrials.

  • Martin Capital Partners's largest Q1 2024 buy was Hershey: 23,510 shares worth $4.57M.
  • Martin Capital Partners added most to Pfizer in Q1 2024, an estimated $2.68M increase.
  • Martin Capital Partners's biggest Q1 2024 reduction was JPMorgan Chase, cutting an estimated $2.97M.
  • Martin Capital Partners fully exited Gilead Sciences in Q1 2024, selling an estimated $3.33M.
  • Martin Capital Partners's ten largest holdings make up 30% of its $261M portfolio in Q1 2024.
  • Martin Capital Partners opened 2 new positions and closed 3 in Q1 2024.
  • Martin Capital Partners's portfolio value rose 6.3% quarter-over-quarter to $261M.

Based on Martin Capital Partners's 13F filing for Q1 2024, filed 5 Apr 2024.